Couverture de Emergency Use & Fast-Tracking- How Safe Is It?

Emergency Use & Fast-Tracking- How Safe Is It?

Emergency Use & Fast-Tracking- How Safe Is It?

Écouter gratuitement

Voir les détails

À propos de cette écoute

 hen normal rules get suspended in the name of urgency, what happens to safety? Dr. Ben Synth explores the controversial world of emergency use authorizations, fast-track designations, and accelerated approvals—pharmaceutical NASCAR where speed matters but crashes can be catastrophic. From COVID-19 vaccines authorized after two months of data to cancer drugs approved based on tumor shrinkage rather than survival, this episode reveals the high-stakes gambles regulatory agencies make during health crises. Discover the difference between emergency use authorization and regular approval, why Aducanumab for Alzheimer's became a lightning rod for criticism, and how HIV activists revolutionized drug development in the 1990s. Learn about breakthrough therapy designations, the weight loss injection phenomenon, and the fundamental tension between patients dying while waiting for perfect data versus accepting higher risks from incomplete evidence. It's the story of regulatory pathways that have saved countless lives while creating unprecedented controversies about the balance between innovation and safety.

Click here to browse handpicked Amazon finds inspired by this podcast series!
https://amzn.to/4iKfAMs
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !

    Ce que les auditeurs disent de Emergency Use & Fast-Tracking- How Safe Is It?

    Moyenne des évaluations utilisateurs. Seuls les utilisateurs ayant écouté le titre peuvent laisser une évaluation.

    Commentaires - Veuillez sélectionner les onglets ci-dessous pour changer la provenance des commentaires.

    Commentaires Audible.fr

    Commentaires Amazon
    Il n'y a pas encore de critique disponible pour ce titre.